COCHLEAR LTD/ADR (OTCMKTS:CHEOY) Stock Rating Lowered by Citigroup

Citigroup lowered shares of COCHLEAR LTD/ADR (OTCMKTS:CHEOY) from a neutral rating to a sell rating in a report released on Wednesday morning, The Fly reports.

Separately, Goldman Sachs Group raised their price target on shares of MEG Energy from C$6.00 to C$7.00 in a research note on Tuesday, April 16th.

Shares of CHEOY stock opened at $76.55 on Wednesday. The business’s 50 day moving average is $72.55. COCHLEAR LTD/ADR has a 12-month low of $56.58 and a 12-month high of $79.66.

About COCHLEAR LTD/ADR

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories.

Further Reading: What is meant by a buy rating?

The Fly

Receive News & Ratings for COCHLEAR LTD/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COCHLEAR LTD/ADR and related companies with MarketBeat.com's FREE daily email newsletter.